US 12134610
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof
granted A61KA61K47/545A61K47/65
Quick answer
US patent 12134610 (Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K47/545, A61K47/65, A61K51/0455, A61K51/0497